| CTG PHARMA S.R.L. Patent applications |
| Patent application number | Title | Published |
|---|
| 20100168216 | PROSTAGLANDIN PHARMACEUTICAL COMPOSITIONS - The present invention relates to new prostaglandin derivatives having improved pharmacological activity and enhanced tolerability. They can be employed for the treatment of glaucoma and ocular hypertension. | 07-01-2010 |
| 20090281093 | ANTI-INFLAMMATORY COMPOUNDS - The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) that release hydrogen sulfide (H | 11-12-2009 |
| 20090275539 | Nuclear Transcription Factors Regulators - The present invention relates to novel compounds that are nuclear transcription factors (NTF) regulators. The present invention also provides methods for treating, preventing and/or reducing inflammation associated diseases by regulating NTF in the cardiovascular, connective tissue, pulmonary, gastrointestinal, respiratory, urogenital, nervous, or cutaneous systems as well as tumoral and infective diseases employing said compounds. | 11-05-2009 |
| 20090036516 | COMPOUNDS FOR TREATING METABOLIC SYNDROME - Compounds of general formula: | 02-05-2009 |
| 20080262031 | 4-Aminoquinoline Derivatives as Antimalarials - New 4-aminoquinoline derivatives having the general formula (I) wherein R, M, X, Y and T have the meaning described in the specification, as potent antimalarials active also on chloroquine-resistant | 10-23-2008 |
